Daan Gene Co., Ltd. announced that the company plans to use its own funds to increase the capital of its wholly-owned subsidiary, Guangzhou Datai Biotechnology Engineering Technology Co., Ltd., by 40 million yuan. After the capital increase, the registered capital of Datai Biotechnology will increase from 30 million yuan to 70 million yuan. This is intended to expand the market for biochemical immune testing reagents and support Datai Biotechnology's market development and research and development registration work.
达安基因：对全资子公司增资4000万元
Daan Gene Co., Ltd.: to increase the capital of its wholly-owned subsidiary by RMB 40 million.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.